Unable to write in log file ../../bases/logs/gimorg/logerror.txt Search | WHO COVID-19 Research Database
Show: 20 | 50 | 100
Results 1 - 3 de 3
Italian Journal of Anatomy and Embryology ; 126(2):55-58, 2022.
Article in English | ProQuest Central | ID: covidwho-2206293


Sepsis (S) can lead to systemic tissue damage, organ failure, and death. [...]early S diagnosis can have a significant impact on patienťs management and prognosis. According to Kang et al, PSEP can also be useful in determining the severity of odontogenic infection and sepsis, and when combined with existing test methods, it is expected to be better in evaluating patient prognosis. [...]according to this study, a PSEP level of 671.5 pg/ml or higher for odontogenic infection can be considered an abnormal level (16). Furthermore, the COVID-19 pandemic has imposed new difficulties and challenges;for example, the use of tele-dentistry, thus modifying the dental practitioner / patient relationship. [...]it would be useful, in dental practice, to introduce the use of markers that can assess the actual risk of sepsis during surgical dental procedures.

Sci Rep ; 11(1): 19817, 2021 10 06.
Article in English | MEDLINE | ID: covidwho-1454815


Recent studies have focused their attention on conjunctivitis as one of the symptoms of coronavirus disease 2019 (COVID-19). Therefore, tear samples were taken from COVID-19 patients and the presence of SARS-CoV-2 was evidenced using Real Time reverse transcription polymerase chain reaction. The main aim of this study was to analyze mRNA expression in the tears of patients with COVID-19 compared with healthy subjects using Next Generation Sequencing (NGS). The functional evaluation of the transcriptome highlighted 25 genes that differ statistically between healthy individuals and patients affected by COVID-19. In particular, the NGS analysis identified the presence of several genes involved in B cell signaling and keratinization. In particular, the genes involved in B cell signaling were downregulated in the tears of COVID-19 patients, while those involved in keratinization were upregulated. The results indicated that SARS-CoV-2 may induce a process of ocular keratinization and a defective B cell response.

COVID-19/genetics , Eye Diseases/virology , Tears/metabolism , Transcriptome , Aged , B-Lymphocytes/metabolism , COVID-19/pathology , COVID-19/virology , Eye Diseases/genetics , Female , High-Throughput Nucleotide Sequencing/methods , Humans , Keratins/metabolism , Male , SARS-CoV-2/isolation & purification , Sequence Analysis, RNA/methods , Skin/metabolism , Skin/pathology , Skin/virology , Tears/virology
Int J Mol Sci ; 21(18)2020 Sep 17.
Article in English | MEDLINE | ID: covidwho-789462


At present, severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection has quickly become a health emergency because no specifics vaccines or drugs, at this moment, are available. Recent studies have shown that the transplantation of mesenchymal stem cells (MSCs) into Coronavirus Disease 2019 (COVID-19) patients could represent a promising strategy for the development of new therapeutic methods. We speculate and suggest that the secretome of human Oral Tissue Stem Cells (hOTSCs), for their immunomodulatory and anti-inflammatory specific properties, could exert beneficial effects on the COVID-19 patients through an innovative aerosolisation technique. This non-invasive technique can offer multiple advantages in prophylaxis, as well as the prevention and treatment of severe epidemic respiratory syndrome with minimum risk and optimal therapeutic effects. This has the potential to create a novel pathway towards immunomodulatory therapy for the treatment of COVID-19 positive patients.

Coronavirus Infections/drug therapy , Immunologic Factors/therapeutic use , Mesenchymal Stem Cells/metabolism , Mouth Mucosa/cytology , Pneumonia, Viral/drug therapy , Proteome/therapeutic use , COVID-19 , Humans , Immunologic Factors/metabolism , Pandemics , Proteome/metabolism , Secretory Pathway